Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.

Inovio Pharmaceuticals Inc. closed $12.93 below its 52-week high ($14.75), which the company achieved on April 1st.

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...

The company priced a public offering of 10 million shares of common stock and accompanying warrants. Discover Fast-Growing Stocks Every Month Inovio Pharmaceuticals Inc INO shares are trading ...

Inovio Pharmaceuticals Inc (INO) stock saw a decline, ending the day at $2.32 which represents a decrease of $-1.44 or -38.30% from the prior close of $3.76. The stock opened at $2.52 and touched a ...

Inovio (INO) Pharmaceuticals announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of its common stock, in an underwritten public ...

In terms of launching INO-3107, Shea and others chose their words ... the title comes from the prospect of potential gain if the stock recovers or snaps back. I do not expect Inovio to experience ...